What do Lipitor users report about daytime sleepiness?
Lipitor, a statin medication used to lower cholesterol levels, can cause a range of side effects. One reported side effect is daytime sleepiness, also known as somnolence. According to the Lipitor patient information leaflet [1], somnolence is a possible side effect of the medication.
How common is daytime sleepiness in Lipitor users?
The exact frequency of daytime sleepiness in Lipitor users is difficult to determine due to varying report levels across different studies. A review of clinical trial data from the FDA shows that somnolence is a reported side effect in 3.1% to 9.2% of patients taking Lipitor [2].
Are patients taking other medications more likely to experience daytime sleepiness?
When taking other medications, such as antidepressants, sedatives, or antihistamines, in combination with Lipitor, patients may experience an increased risk of daytime sleepiness. The combination of medications can lead to additive side effects, including sleepiness.
What alternatives are there for Lipitor users experiencing daytime sleepiness?
For patients experiencing daytime sleepiness while taking Lipitor, it may be worth discussing alternatives with their healthcare provider. Other statins, such as Crestor, Pravachol, or Zocor, may have a different side effect profile.
How long do Lipitor users experience daytime sleepiness?
The duration of daytime sleepiness in Lipitor users can vary. Some patients may experience side effects immediately after starting the medication, while others may not experience side effects until after continued use.
Who is more likely to experience daytime sleepiness?
Certain individuals may be more susceptible to experiencing daytime sleepiness while taking Lipitor. These may include:
* Elderly individuals
* Patients with underlying medical conditions (e.g., sleep apnea, hypothyroidism)
* Patients taking multiple medications
References
[1] Pfizer. (2022). Lipitor (atorvastatin calcium) tablets, film-coated. Patient information.
[2] FDA. (2022). Lipitor (atorvastatin calcium). Adverse event data.
According to DrugPatentWatch.com, the patent for Lipitor expired in 2011 [3].
Source information:
1. Pfizer. (2022). Lipitor (atorvastatin calcium) tablets, film-coated. Patient information.
2. FDA. (2022). Lipitor (atorvastatin calcium). Adverse event data.
3. DrugPatentWatch. (2022). Lipitor (atorvastatin) patent expired 2011.